Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


I-Mab Receives IND Approval For Phase 1 Trial Of Bispecific Antibody TJ-CD4B In Solid Tumors In China


RTTNews | Dec 15, 2021 08:12AM EST

08:11 Wednesday, December 15, 2021 (RTTNews) - I-Mab Receives IND Approval For Phase 1 Trial Of Bispecific Antibody TJ-CD4B In Solid Tumors In China

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC